FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Cefixime Oral Capsules
Status: Currently in Shortage
»Date first posted: 01/21/2022
»Therapeutic Categories: Anti-Infective

Expand all

Ascend Laboratories LLC. (Revised 03/16/2022)

Company Contact Information:
201-326-9004

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
400 mg (50’s HDPE Bottle pack)(NDC 67877-584-50) Currently unavailable, Estimated recovery: June/July 2022 Requirements related to complying with good manufacturing practices

Lupin (Reverified 03/03/2022)

Company Contact Information:
866-587-4617

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
400 mg Bottle of 50 capsules (NDC 68180-423-08) Limited availability, Manufacturing and distribution is ongoing. Demand increase for the drug
400 mg Unit dose Package of 10 (1 blister of 10 capsules) (NDC 68180-423-11) Limited availability, Manufacturing and distribution is ongoing. Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English